Obstructive Sleep Apnea: What It Is, How It's Diagnosed, and What Actually Treats It
Obstructive sleep apnea is the most common and most under-recognized breathing disorder in adult medicine. It is also one of the most treatable. This page is the clinical map: what OSA actually is, the symptoms that get missed, how it is tested for, and every treatment path worth knowing about.
Medically reviewed by Dr. Shantan Ravula · August 9, 2026
Obstructive sleep apnea (OSA) is what happens when the muscles that hold your upper airway open relax during sleep and the airway narrows or collapses. Breathing slows or stops, oxygen falls, and the brain briefly wakes you up just enough to restore airflow. You usually don't remember any of it. Then it happens again, sometimes hundreds of times a night, every night, for years.
That repetition is what makes OSA a whole-body condition rather than a snoring problem. Each event triggers a surge of stress hormones, a jump in blood pressure, and a fragment of lost sleep. Multiply that by a decade and you get the associations clinicians care about: hypertension that resists medication, type 2 diabetes that won't budge, atrial fibrillation, daytime sleepiness serious enough to affect driving, and a quality of life people often don't realize they've lost until it comes back.
This page is educational, not medical advice. It is written to give you an accurate map of the condition so the conversation with your clinician starts further along.
The symptoms people notice — and the ones they miss
The classic picture is a loud snorer whose partner has watched them stop breathing. That picture is real, but it describes maybe half of the people who have OSA. Plenty of patients have no bed partner to report anything, and plenty snore only lightly. Relying on the stereotype is the single biggest reason an estimated majority of cases go undiagnosed.
The nighttime signals worth taking seriously: snoring that is loud or has become louder, witnessed pauses, gasping or choking awakenings, waking to urinate more than once, night sweats, and restless, thrashing sleep. The morning signals: a headache in the first hour after waking, a dry mouth or raw throat, and the feeling of having slept without being restored. If you wake up parched, the mechanism behind that is worth understanding on its own — see mouth breathing and dry throat at night and what your morning symptoms are telling you.
The daytime signals are the ones most often blamed on something else: sleepiness that shows up in meetings or behind the wheel, brain fog, irritability, low mood, reduced exercise tolerance, and a fatigue that sleeping longer doesn't fix. That last distinction matters clinically — fatigue and sleepiness are not the same complaint, and OSA can present as either. In some adults and many children, the presentation is inattention and restlessness rather than tiredness, which is why the ADHD and sleep apnea overlap is worth knowing about.
And a point that surprises people: you don't have to fully stop breathing to have sleep apnea. Partial airway narrowing that limits airflow, called a hypopnea, counts. So do arousals driven by increased breathing effort. A great many patients have been told their breathing "looked fine" when what they actually had was a flow-limited airway working overtime all night.
Who is at risk, and why the risk profile is wider than you think
Excess weight is the strongest modifiable risk factor, particularly fat deposited around the neck, tongue, and abdomen, which narrows the airway and reduces lung volumes that would otherwise help hold it open. But weight is a risk factor, not a requirement. Airway anatomy does a lot of the work: a small or set-back jaw, a large tongue, crowded oropharynx, high-arched palate, enlarged tonsils, or chronic nasal obstruction can all produce significant OSA in someone with a completely ordinary BMI.
That anatomical contribution is why body size is a poor screening tool in some populations. South Asian patients in particular develop metabolic and airway risk at BMIs considered normal by standard cutoffs. Age raises risk steadily. Men are affected earlier, but the gap narrows sharply after menopause — hormonal change is a genuine inflection point, covered in perimenopause as a sleep and metabolic turning point. Alcohol and sedatives relax the airway further, and family history matters independently of weight.
How OSA is diagnosed
Diagnosis requires an objective sleep study — a questionnaire alone cannot make or exclude the diagnosis. For most adults with suspected uncomplicated moderate-to-severe OSA, a home sleep apnea test is appropriate: a small device worn for one or more nights that records airflow, breathing effort, oxygen saturation, and pulse. In-laboratory polysomnography remains the more complete test and is preferred when there is significant cardiopulmonary disease, suspected central apnea or hypoventilation, another suspected sleep disorder, or when a home test is negative in someone whose story still fits.
Results are usually summarized as an apnea-hypopnea index (AHI): events per hour of sleep, conventionally grouped as mild (5–15), moderate (15–30), and severe (30+). Treat that number as a starting point rather than a verdict. Two people with an identical AHI can have very different physiology — one with brief events and stable oxygen, another with prolonged desaturations and heavy autonomic load. We wrote about exactly this in same score, different disease. What your oxygen does, how fragmented your sleep is, how sleepy you are, and what your heart and metabolism look like all belong in the interpretation.
Treatment: what works, and how to choose
There is no single right treatment for OSA. There is a right treatment for your airway, your severity, and the therapy you will actually use every night — adherence is the variable that determines outcomes more than any other.
Positive airway pressure (CPAP)
CPAP remains the most reliably effective therapy across all severities: a stream of pressurized air that splints the airway open. Used consistently, it improves sleepiness, blood pressure, and quality of life, and the cardiovascular outcomes evidence is more nuanced but meaningfully favorable in adherent users. The full practical guide — pressure settings, masks, humidification, side effects, and troubleshooting — lives in our CPAP therapy hub. If you have tried CPAP and abandoned it, that is a solvable clinical problem far more often than patients are told.
Oral appliance therapy
A custom mandibular advancement device moves the lower jaw forward to enlarge the airway. It is generally less effective than CPAP at reducing AHI but often better tolerated, which can make real-world outcomes competitive in mild to moderate disease. Best fitted by a dentist trained in dental sleep medicine, with a follow-up study to confirm it is working.
Weight-directed and metabolic treatment
Weight reduction lowers AHI in a dose-dependent way and improves the metabolic disease that so often travels with OSA. The arrival of GLP-1 and GIP/GLP-1 medications changed this conversation substantially: tirzepatide now has direct trial evidence in OSA, and the coverage, eligibility, and expectations picture is laid out in GLP-1 medications and sleep apnea. Weight-directed treatment is a complement to airway therapy, not a reason to delay it — the airway needs support tonight, not in nine months.
Positional and nasal treatment
Some patients have supine-predominant disease, where events cluster almost entirely on the back. Devices and trainers that keep you off your back can produce a genuine reduction in those cases, verified with a repeat study. Treating nasal obstruction — allergic rhinitis, septal deviation, turbinate hypertrophy — rarely cures OSA on its own, but it improves CPAP comfort and pressure tolerance enough to be worth doing.
Surgical and stimulation options
For selected patients, upper airway surgery, orthognathic (jaw advancement) surgery, or hypoglossal nerve stimulation are appropriate. These are anatomy-specific decisions requiring specialist evaluation, usually after PAP therapy has been genuinely optimized and still failed.
What we deliberately do not recommend as a substitute for treatment: sedating sleep aids taken to "sleep through" the problem. If breathing is the cause of the awakenings, sedation addresses the alarm rather than the fire, and some agents relax the airway further. The honest evidence review on that is in our sleep aids and medications guide, and the supplement and lifestyle claims are assessed in natural remedies for sleep apnea.
Variants and related airway problems
Positional sleep apnea
Defined as an AHI at least twice as high while sleeping on the back compared with other positions. Gravity pulls the tongue and soft palate backward when supine, and in a subset of patients that accounts for nearly all their events. Worth identifying, because the treatment is unusually simple.
Central sleep apnea
In central sleep apnea the airway is open but the brain briefly stops sending the signal to breathe. It looks different on a study and is treated differently. It is more common with heart failure, opioid use, stroke, and at altitude, and it can also emerge when PAP therapy is started for obstructive disease. Any suspicion of central events is a reason for in-lab testing rather than a home study.
Sleep-related hypoxemia and obesity hypoventilation
Some patients spend long stretches of the night with low oxygen without dramatic discrete events. Obesity hypoventilation syndrome — daytime elevated carbon dioxide with obesity and sleep-disordered breathing — is the most serious version and often needs bilevel rather than CPAP support. Low overnight oxygen deserves explanation in its own right, not just an AHI number.
COPD–OSA overlap syndrome
Having both COPD and OSA is worse than having either alone: oxygen levels fall further and stay down longer overnight, and outcomes are meaningfully better with treated than untreated sleep-disordered breathing. Anyone with COPD and daytime sleepiness, morning headache, or unexplained pulmonary hypertension should be evaluated for OSA.
Nocturia and GERD at night
Getting up to urinate two or more times a night is one of the most overlooked presenting symptoms of OSA. The intrathoracic pressure swings from obstructed breathing stretch the heart and release atrial natriuretic peptide, which tells the kidneys to make urine. Those same pressure swings pull stomach contents upward, which is why nighttime reflux and OSA travel together so frequently. Both often improve when the breathing is treated.
What untreated OSA does over time
The cardiometabolic picture is the reason clinicians push on this. Untreated OSA is associated with hypertension — particularly blood pressure that fails to dip overnight and spikes in the early morning — with atrial fibrillation, with worsened insulin resistance, and with a bidirectional relationship with type 2 diabetes in which each condition makes the other harder to control. The sleep and metabolic loop runs in both directions: poor sleep drives appetite and insulin resistance, and metabolic disease worsens the airway.
There is also a cognitive and neurologic cost. Chronic sleep fragmentation blocks the restorative work of deep sleep and the clearance processes that depend on it, and untreated sleep-disordered breathing is an area of active research in cognitive decline. None of this is a reason to panic. It is a reason to test.
Getting evaluated
If several of the symptoms above are familiar, the next step is straightforward: an evaluation with a clinician who treats sleep-disordered breathing, and, when indicated, an objective sleep study. Access is a real barrier for many patients, which is a problem we write about directly in our sleep care access guide. It is also the reason we built a testing and treatment pathway that starts at home.
Not sure whether your symptoms warrant testing? The SOMOS baseline assessment takes a few minutes and is reviewed by our clinical team.
Frequently asked questions
Can you have sleep apnea without snoring?
Yes. Snoring is the most familiar sign of obstructive sleep apnea, but it is not required for the diagnosis. Some people have quiet airway collapse, some sleep alone and have no one to report snoring, and some present mainly with daytime sleepiness, morning headache, nighttime urination, or unrefreshing sleep. A diagnosis is made from an objective sleep study, not from whether snoring is present.
Can you have sleep apnea if you are not overweight?
Yes. Excess weight is the strongest modifiable risk factor, but airway anatomy causes plenty of cases in people with a normal BMI — a small or set-back jaw, a large tongue, crowded throat, enlarged tonsils, or chronic nasal obstruction. Body size is also a poor screening tool in some populations, including South Asian patients, who can carry substantial metabolic and airway risk at BMIs considered normal.
Is a home sleep apnea test as good as an in-lab study?
For most adults with a high likelihood of uncomplicated moderate-to-severe obstructive sleep apnea, a home sleep apnea test is an accepted and accurate way to make the diagnosis, and it is far easier to access. In-lab polysomnography is preferred when there is significant heart or lung disease, suspected central sleep apnea or hypoventilation, another suspected sleep disorder, or when a home test comes back negative but symptoms still strongly suggest apnea.
Does sleep apnea ever go away on its own?
It can improve substantially when an underlying driver changes — meaningful weight loss, treatment of nasal obstruction, stopping alcohol or sedatives near bedtime, or in children, removal of enlarged tonsils and adenoids. It rarely resolves spontaneously without one of those changes, and improvement should be confirmed with a repeat sleep study rather than assumed. Age tends to push the risk in the other direction.
What happens if sleep apnea goes untreated?
Untreated obstructive sleep apnea is associated with persistent daytime sleepiness and impaired concentration, a higher risk of motor vehicle accidents, hypertension that is harder to control, atrial fibrillation, worsened insulin resistance and type 2 diabetes control, and reduced quality of life. Risk relates to severity, oxygen burden, and how long it has gone untreated, and much of it improves with consistent therapy.
Do GLP-1 medications treat sleep apnea?
Tirzepatide has direct randomized trial evidence showing meaningful reductions in apnea-hypopnea index in adults with obesity and moderate-to-severe obstructive sleep apnea, and it carries an FDA indication for that population. Weight reduction more broadly lowers apnea severity in a dose-dependent way. That said, these medications complement airway therapy rather than replace it — the airway needs support while weight change is underway, and improvement should be confirmed with repeat testing.
References
- 1.American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd edition, text revision (ICSD-3-TR). 2023.
- 2.Kapur VK, et al. Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea. Journal of Clinical Sleep Medicine. 2017. https://doi.org/10.5664/jcsm.6506
- 3.Patil SP, et al. Treatment of adult obstructive sleep apnea with positive airway pressure: an AASM clinical practice guideline. Journal of Clinical Sleep Medicine. 2019. https://doi.org/10.5664/jcsm.7640
- 4.Malhotra A, et al. Tirzepatide for the treatment of obstructive sleep apnea and obesity. New England Journal of Medicine. 2024. https://doi.org/10.1056/NEJMoa2404881
- 5.Benjafield AV, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea. The Lancet Respiratory Medicine. 2019. https://doi.org/10.1016/S2213-2600(19)30198-5
- 6.Ramar K, et al. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy. Journal of Clinical Sleep Medicine. 2015. https://doi.org/10.5664/jcsm.4858